Roman Butler Fullerton & CO Medtronic PLC Transaction History

Roman Butler Fullerton & CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$76.72 - $87.58 $198,934 - $227,094	2,593 New	2,593 $209,000
Q2 2022 Jul 26, 2022	SELL	$87.4 - $113.09 $194,639 - $251,851	-2,227 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$100.58 - $112.38 $223,991 - $250,270	2,227 New	2,227 $247,000
Q4 2021 Jan 24, 2022	SELL	$99.53 - $127.75 $215,382 - $276,451	-2,164 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$122.75 - $135.17 $1,350 - $1,486	11 Added 0.51%	2,164 $261,000
Q2 2021 Jul 29, 2021	BUY	$118.19 - $131.5 $1,063 - $1,183	9 Added 0.42%	2,153 $267,000
Q1 2021 Apr 22, 2021	BUY	$111.18 - $119.74 $8,004 - $8,621	72 Added 3.47%	2,144 $270,000
Q4 2020 Feb 01, 2021	BUY	$100.57 - $117.14 $1,005 - $1,171	10 Added 0.48%	2,072 $243,000
Q3 2020 Oct 15, 2020	BUY	$90.13 - $108.78 $185,848 - $224,304	2,062 New	2,062 $214,000
Q1 2020 Apr 13, 2020	SELL	$72.92 - $121.3 $140,298 - $233,381	-1,924 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$104.49 - $114.54 $940 - $1,030	9 Added 0.47%	1,924 $218,000
Q3 2019 Oct 15, 2019	BUY	$98.02 - $111.18 $187,708 - $212,909	1,915 New	1,915 $208,000

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $115B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

Stay updated on Roman Butler Fullerton & CO with notifications on news.